Real World Evidence Lead

BioMarin Pharmaceutical Inc. • San Rafael, CA

9d

About The Position

The Real World Evidence Lead is part of the Integrated Evidence function, which comprises subject matter experts in evidence planning, observational study design, and data interpretation. This function aims to drive excellence in evidence planning and implement novel study design approaches to generate robust evidence. This evidence enhances the understanding of unmet medical needs, supports patient and endpoint selection for clinical studies, and informs medical practice regarding the appropriate use, long-term safety, and effectiveness of BioMarin products to drive clinical adoption.

Requirements

• A combination of academic training and practical experience in Epidemiology is required.
• Doctoral degree (PhD, ScD, or DrPH) or Master’s of Public Health in Epidemiology/Pharmacoepidemiology and at least 8 years of experience leading epidemiologic research in the pharmaceutical industry.
• Doctoral degree (PhD, ScD or DrPH) or Master’s degree in a relevant discipline (ie. Health services research, health outcomes research, public health, statistics, or pharmaceutical sciences) with at least 10 years of experience leading epidemiologic research in the pharmaceutical setting.
• Demonstrated leadership in pharmacoepidemiologic and real-world evidence research within (or in support of) the pharmaceutical/biotechnology industry, with accountability for study strategy and delivery.
• Proven ability to translate integrated evidence strategy into executable study concepts and protocol portfolios, ensuring alignment to program priorities and measurable decision needs.
• Extensive experience authoring and/or providing final scientific accountability for protocol concept documents, study protocols, statistical analysis plans, and study reports (including directing contributions from matrix partners and vendors).
• Deep expertise in observational study design and advanced analytic methods, with strong grasp of bias/confounding mitigation, data quality assessment, and fit-for-purpose inference.
• Strong understanding of healthcare data ecosystems and standards (e.g., HL7, FHIR), clinical terminologies (e.g., ICD-10), EMR/claims data, and data governance/privacy requirements (e.g., GDPR, HIPAA).
• Demonstrated capability to lead high-stakes engagement with regulators and ethics bodies (e.g., HA queries, IRB/EC questions), shaping responses that protect scientific integrity, timelines, and program objectives.
• Ability to set priorities and drive delivery in a business-driven, matrix environment—balancing multiple workstreams through strong planning, stakeholder management, risk management, and operational discipline.
• Proven ability to build credibility and influence at all levels (including senior leadership), with the ability to translate complex evidence into clear implications and recommendations for internal decision-making and external scientific dissemination.

Nice To Haves

• Experience in rare disease epidemiology and/or genetic epidemiology, including working with small populations, registries, and novel endpoints.

Responsibilities

• Setting and leading the strategy for real-world/observational evidence generation across assigned program(s) or therapy area(s), aligning to the Integrated Evidence Plan and key value, access, and regulatory decision points.
• Leading implementation of real-world evidence studies in-line with a product’s Integrated Evidence Plan.
• Lead protocol development and reporting for disease understanding studies (retrospective and prospective), ensuring fit-for-purpose design to characterize target populations (risk factors, natural history, burden of illness, treatment patterns, comorbidities/comedications, outcomes, and unmet need) and to inform program decisions.
• Lead the post-marketing evidence strategy and delivery (including safety/effectiveness studies and registries), overseeing evaluation of risk mitigation strategies and ensuring alignment to risk management plans and real-world regulatory commitments.
• Establish and lead implementation of research plans with external collaborators (CROs, academia, data partners), working effectively to oversee external groups through the research process to ensure delivery of high-quality outputs.
• Define and oversee secondary data analysis strategy using BioMarin clinical and real-world data, ensuring analytic rigor and interpretation that directly supports program strategy and evidence gaps.
• Lead interpretation and synthesis of real-world evidence to deliver clear implications and recommendations for internal governance and senior stakeholders, and drive external scientific dissemination (manuscripts, abstracts, posters, presentations) consistent with publication strategy.
• Serve as a strategic evidence partner to Commercial, Market Access, and Regulatory, ensuring real-world evidence is appropriately reflected in forecasts, value narratives, and key regulatory deliverables (e.g., Orphan Drug Designation applications and regulatory strategy documents).

What This Job Offers

• Job Type: Full-time
• Career Level: Director